Clinical Orthopaedics and Related Research®

, Volume 469, Issue 10, pp 2874–2880 | Cite as

Tranexamic Acid Reduces Blood Loss and Blood Transfusion after TKA: A Prospective Randomized Controlled Trial

  • Keerati Charoencholvanich
  • Pichet Siriwattanasakul
Clinical Research



TKA may be associated with considerable blood loss, and transfusion carries substantial risk of immunologic reaction and disease transmission. Blood transfusion also involves additional cost, therefore a reduction in its use is important. Several methods reportedly reduce postoperative blood loss and avoid homologous blood transfusion with traditional TKA approaches, but it is unclear these reductions apply to a minimally invasive technique.


We asked whether tranexamic acid administration could reduce blood loss and blood transfusion requirements after TKA.

Patients and Methods

Between March 2008 and May 2008, we enrolled 100 patients with primary osteoarthritis undergoing a unilateral cemented TKA in a prospective, randomized, double-blind study. Patients were randomized into one of two groups: the control group received a placebo and the study group received tranexamic acid intravenously (10 mg/kg) 10 minutes before inflation of the tourniquet and 3 hours postoperatively and orally (250 mg/capsule; two capsules three times daily) for 5 days. We measured volume of drained blood 48 hours postoperatively, decrease in hemoglobin levels 12 hours postoperatively, amount of blood transfused, and number of patients requiring allogenic blood transfusion. The minimum followup was 6 months (mean, 10.4 months; range, 6–12 months).


Mean (± SD) postoperative volume of drained blood was lower in the group receiving tranexamic acid (727.50 ± 234 mL) than in control subjects (1208.77 ± 421 mL). The mean hemoglobin decrease 12 hours postoperatively was lower in patients receiving tranexamic acid (2.12 ± 0.64 g/dL) than in control subjects (3.33 ± 0.88 g/dL). The amount of blood transfused and number of patients requiring blood transfusion were lower in patients receiving tranexamic acid than in control subjects.


Tranexamic acid reduced postoperative blood loss after TKA, as reflected in reduction in the number of blood transfusions. We did not observe any change in symptomatic thromboembolic phenomenon.

Level of Evidence

Level 1, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.


  1. 1.
    Adalberth G, Bystrom S, Kolstad K, Mallmin H, Millbrink J. Postoperative drainage of knee arthroplasty is not necessary: a randomized study of 90 patients. Acta Orthop Scand. 1998;69:475–478.PubMedCrossRefGoogle Scholar
  2. 2.
    Aglietti P, Baldini A, Vena LM, Abbate R, Fedi S, Falciani M. Effect of tourniquet use on activation of coagulation in total knee arthroplasty. Clin Orthop Relat Res. 2000;371:169–177.PubMedCrossRefGoogle Scholar
  3. 3.
    Alvarez JC, Santiveri FX, Ramos I, Vela E, Puig L, Escolano F. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion. 2008;48:519–525.PubMedCrossRefGoogle Scholar
  4. 4.
    Andersson L, Nilsson IM, Nilehn JE, Hedner U, Granstrand B, Melander B. Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand J Haematol. 1965;2:230–247.PubMedCrossRefGoogle Scholar
  5. 5.
    Benoni G, Bjorkman S, Fredin H. Application of pharmacokinetic data from healthy volunteers for the prediction of plasma concentrations of tranexamic acid in surgical patients. Clin Drug Invest. 1995:10:280–287.CrossRefGoogle Scholar
  6. 6.
    Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br. 1996;78:434–440.PubMedGoogle Scholar
  7. 7.
    Camarasa MA, Olle G, Serra-Prat M, Martín A, Sánchez M, Ricós P, Pérez A, Opisso L. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth. 2006;96:576–582.PubMedCrossRefGoogle Scholar
  8. 8.
    Cid J, Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion. 2005;45:1302–1307.PubMedCrossRefGoogle Scholar
  9. 9.
    Clements DH, Sculco TP, Burke SW, Mayer K, Levine DB. Salvage and reinfusion of postoperative sanguineous wound drainage: a preliminary report. J Bone Joint Surg Am. 1992;74:646–651.PubMedGoogle Scholar
  10. 10.
    Dalen T, Brostrom LA, Engtrom KG. Autotransfusion after total knee arthroplasty: effects on blood cells, plasma chemistry, and whole blood rheology. J Arthroplasty. 1997;12:517–525.PubMedCrossRefGoogle Scholar
  11. 11.
    Dubber AH, McNicol GP, Douglas AS. Amino methyl cyclohexane carboxylic acid (AMCHA): a new synthetic fibrinolytic inhibitor. Br J Haematol. 1965;11:237–245.PubMedCrossRefGoogle Scholar
  12. 12.
    Engel JM, Hohaus T, Ruwoldt R, Menges T, Jürgensen I, Hempelmann G. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg. 2001;92:775–780.PubMedCrossRefGoogle Scholar
  13. 13.
    Eriksson O, Kjellman H, Pillbrant A, Schannong M. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. Eur J Clin Pharmacol. 1974;7:375–380.PubMedCrossRefGoogle Scholar
  14. 14.
    Fahmy NR, Patel DG. Hemostatic changes and postoperative deep-vein thrombosis associated with use of a pneumatic tourniquet. J Bone Joint Surg Am. 1981;63:461–465.PubMedGoogle Scholar
  15. 15.
    Fiebig E. Safety of the blood supply. Clin Orthop Relat Res. 1998;357:6–18.PubMedCrossRefGoogle Scholar
  16. 16.
    Gannon DM, Lombardi AV Jr, Mallory TH, Vaughn BK, Finney CR, Niemcryk S. An evaluation of the efficacy of postoperative blood salvage after total joint arthroplasty: a prospective randomized trial. J Arthroplasty. 1991;6:109–114.PubMedCrossRefGoogle Scholar
  17. 17.
    Gascon P, Zoumbos NC, Young NS. Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med. 1984;100:173–177.PubMedGoogle Scholar
  18. 18.
    Gibbons CE, Solan MC, Ricketts DM, Patterson M. Cryotherapy compared with Robert Jones bandage after total knee replacement: a prospective randomized trial. Int Orthop. 2001;25:250–252.PubMedCrossRefGoogle Scholar
  19. 19.
    Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth. 2003;90:596–599.PubMedCrossRefGoogle Scholar
  20. 20.
    Groh Gl, Buchert PK, Allen WC. A comparison of transfusion requirements after total knee arthroplasty using the Solcotrans autotransfusion system. J Arthroplasty. 1990;5:281–285.PubMedCrossRefGoogle Scholar
  21. 21.
    Han CD, Shin DE. Postoperative blood salvage and reinfusion after total joint arthroplasty. J Arthroplasty. 1997;12:511–516.PubMedCrossRefGoogle Scholar
  22. 22.
    Heddle NM, Klama LN, Griffith L, Roberts R, Shukla G, Kelton JG. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion. 1993;33:794–797.PubMedCrossRefGoogle Scholar
  23. 23.
    Hiippala ST, Strid LJ, Wennerstrand MI, Arvela JV, Niemelä HM, Mäntylä SK, Kuisma RP, Ylinen JE. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg. 1997;84:839–844.PubMedGoogle Scholar
  24. 24.
    Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care. 2003;31:529–537.PubMedGoogle Scholar
  25. 25.
    Howes JP, Sharma V, Cohen AT. Tranexamic acid reduces blood loss after knee arthroplasty. J Bone Joint Surg Br. 1996;78:995–996.PubMedCrossRefGoogle Scholar
  26. 26.
    Hoylaerts M, Lijnen HR, Collen D. Studies on the mechanism of antifibrinolytic action of tranexamic acid. Biochim Biophys Acta. 1981;673:75–85.PubMedGoogle Scholar
  27. 27.
    Hynes M, Calder P, Scott G. The use of tranexamic acid to reduce blood loss during total knee arthroplasty. Knee. 2003;10:375–377.PubMedCrossRefGoogle Scholar
  28. 28.
    Jansen AJ, Andreica S, Claeys M, D’Haese J, Camu F, Jochmans K. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth. 1999;83:596–601.PubMedGoogle Scholar
  29. 29.
    Janssens M, Joris J, David JL, Lemaire R, Lamy M. High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology. 1994;80:23–29.PubMedCrossRefGoogle Scholar
  30. 30.
    Juelsgaard P, Larsen UT, Sorensen JV, Madsen F, Soballe K. Hypotensive epidural anesthesia in total knee replacement without tourniquet: reduced blood loss and transfusion. Reg Anesth Pain Med. 2001;26:105–110.PubMedGoogle Scholar
  31. 31.
    Klenerman L, Chakrabarti R, Mackie I, Brozovic M, Stirling Y. Changes in haemostatic system after application of a tourniquet. Lancet. 1977;1:970–972.PubMedCrossRefGoogle Scholar
  32. 32.
    Kruithof EK, Nicolosa G, Bachmann F. Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Blood. 1987;70:1645–1653.PubMedGoogle Scholar
  33. 33.
    Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty: a prospective, randomized, multicenter study. J Bone Joint Surg Am. 1999;81:1580–1588.PubMedGoogle Scholar
  34. 34.
    Martin JW, Whiteside LA, Milliano MT, Reedy ME. Postoperative blood retrieval and transfusion in cementless total knee arthroplasty. J Arthroplasty. 1992;7:205–210.PubMedCrossRefGoogle Scholar
  35. 35.
    Molloy DO, Archbold HA, Ogonda L,McConway J, Wilson RK, Beverland DE. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective randomised controlled trial. J Bone Joint Surg Br. 2007;89:306–309.PubMedCrossRefGoogle Scholar
  36. 36.
    Nakahara M, Sakahashi H. Effect of application of a tourniquet on bleeding factors in dogs. J Bone Joint Surg Am. 1967;49:1345–1351.PubMedGoogle Scholar
  37. 37.
    Newman JH, Bowers M, Murphy J. The clinical advantages of autologous transfusion: a randomized, controlled study after knee replacement. J Bone Joint Surg Br. 1997;79:630–632.PubMedCrossRefGoogle Scholar
  38. 38.
    Nilsson IM. Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (R Coll Pathol). 1980;14:41–47.Google Scholar
  39. 39.
    Orpen NM, Little C, Walker G, Crawfurd EJ. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee. 2006;13:106–110.PubMedCrossRefGoogle Scholar
  40. 40.
    Petaja J, Myllynen P, Myllyla G, Vahtera E. Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand. 1987;153:647–651.PubMedGoogle Scholar
  41. 41.
    Prasad N, Padmanabhan V, Mullaji A. Comparison between two methods of drain clamping after total knee arthroplasty. Arch Orthop Trauma Surg. 2005;125:381–384.PubMedCrossRefGoogle Scholar
  42. 42.
    Raleigh E, Hing CB, Hanusiewicz AS, Fletcher SA, Price R. Drain clamping in knee arthroplasty: a randomized controlled trial. ANZ J Surg. 2007;77:333–335.PubMedCrossRefGoogle Scholar
  43. 43.
    Raut VV, Stone MH, Wroblewski BM. Reduction of postoperative blood loss after press-fit condylar knee arthroplasty with use of a femoral intramedullary plug. J Bone Joint Surg Am. 1993;75:1356–1357.PubMedGoogle Scholar
  44. 44.
    Risberg B. The response of the fibrinolytic system in trauma. Acta Chir Scand Suppl. 1985;522:245–271.PubMedGoogle Scholar
  45. 45.
    Roy N, Smith M, Anwar M, Elsworth C. Delayed release of drain in total knee replacement reduces blood loss: a prospective randomised study. Acta Orthop Belg. 2006;72:34–38.PubMedGoogle Scholar
  46. 46.
    Ryu J, Sakamoto A, Honda T, Saito S. The postoperative drain-clamping method for hemostasis in total knee arthroplasty: reducing postoperative bleeding in total knee arthroplasty. Bull Hosp Jt Dis. 1997;56:251–254.PubMedGoogle Scholar
  47. 47.
    Sakahashi H, Sato E, Ishima T. A means for control of bleeding during and after the artificial knee joint replacement operation (combined use of antiplasmin and the drain clamp method). Jpn Soc Replacement Arthroplasty. 1998;28:67–68.Google Scholar
  48. 48.
    Sakihara H. [A method to control postoperative bleeding after total knee replacement] [in Japanese]. Seikei-saigaigeka. 1988;31:543–545.Google Scholar
  49. 49.
    Sano M, Hakusui H, Kojima C, Akimoto T. Absorption and excretion of tranexamic acid following intravenous, intramuscular and oral administrations in healthy volunteers. Jpn J Clin Pharmacol Therapeutics. 1976;7:375–382.Google Scholar
  50. 50.
    Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion transmitted viral infections: the Retrovirus Epidemiology Donor Study. N Engl J Med. 1996;334:1685–1690.PubMedCrossRefGoogle Scholar
  51. 51.
    Shen PC, Jou IM, Lin YT, Lai KA, Yang CY, Chern TC. Comparison between 4-hour clamping drainage and nonclamping drainage after total knee arthroplasty. J Arthroplasty. 2005;20:909–913.PubMedCrossRefGoogle Scholar
  52. 52.
    Sinha A, Sinha M, Burgert S. Reinfusion of drained blood as an alternative to homologous blood transfusion after total knee replacement. Int Orthop. 2001;25:257–259.PubMedCrossRefGoogle Scholar
  53. 53.
    Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br. 2001;83:702–705.PubMedCrossRefGoogle Scholar
  54. 54.
    Tsumara N, Yoshiya S, Chin T, Shiba R, Kohso K, Doita M. A prospective comparison of clamping the drain or post-operative salvage of blood in reducing blood loss after total knee arthroplasty. J Bone Joint Surg Br. 2006;88:49–53.PubMedCrossRefGoogle Scholar
  55. 55.
    Veien M, Sorensen JV, Madsen F, Juelsgaard P. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand. 2002;46:1206–1211.PubMedCrossRefGoogle Scholar
  56. 56.
    Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 1985;29:236–261.PubMedCrossRefGoogle Scholar
  57. 57.
    Walzman M, Bonnar J. Effects of tranexamic acid on the coagulation and fibrinolytic systems in pregnancy complicated by placental bleeding. Arch Toxicol Suppl. 1982;5:214–220.PubMedGoogle Scholar
  58. 58.
    Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, Mayers SL, Spotnitz WD. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am. 2001;83:1503–1505.PubMedGoogle Scholar
  59. 59.
    Yamada K, Imaizumi T, Uemura M, Takada N, Kim Y. Comparison between 1-hour and 24-hour drain clamping using diluted epinephrine solution after total knee arthroplasty. J Arthroplasty. 2001;16:458–462.PubMedCrossRefGoogle Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2011

Authors and Affiliations

  • Keerati Charoencholvanich
    • 1
  • Pichet Siriwattanasakul
    • 1
  1. 1.Department of Orthopedic Surgery, Faculty of MedicineSiriraj Hospital, Mahidol UniversityBangkokThailand

Personalised recommendations